BioInvent International AB (publ) (BINV)

Nasdaq Stockholm | Biotech | Biotech / Immuno-oncology
Free
No email, no account, no signup.
Pulling latest news for BioInvent International AB (publ)…
Bull
Bear
Preliminary read — single AI model. The deep report cross-checks with four.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
Nasdaq Stockholm
Type
Biotech
Sector
Biotech / Immuno-oncology
Market Cap
$159M
We're already tracking BioInvent International AB (publ) — here are the latest events we've registered

Recent News

  • On April 29, 2026, BioInvent reported its Q1 2026 results, ending the period with SEK 456.5 million in liquid funds. The company also announced that clinical data for its lead candidate BI-1808 in combination with pembrolizumab will be presented at the 2026 ASCO Annual Meeting.
Want to know how this news affects BioInvent International AB (publ)? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of BioInvent International AB (publ) will be delivered in the same format.

Sample analyses in the same sector

Click to see what a complete analysis looks like.

Swedish Orphan Biovitrum AB (publ)
SOBI
HOLD
Liquidia Corporation
LQDA
BUY
Cereno Scientific B
CRNO B
HOLD
Dyne Therapeutics, Inc.
DYN
NEUTRAL
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
BioInvent International AB (publ) (BINV)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.